Hao Yu

Hao Yu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
GSGaocheng Shi
Gaocheng Shi
HMHuihui Meng
Huihui Meng
ZZZongmeng Zhang
Zongmeng Zhang
GZGuanglei Zhang
Guanglei Zhang
YLYanran Li
Yanran Li
HYHao Yu
Hao Yu
Background/Objectives: Myocardial ischemia–reperfusion injury (MIRI) is characterized by the exacerbation of tissue damage following the restoration of blood flow to the myocardium. Chuju, recognized for its homology of food and medicine, is derived from the dried capitulum of Dendranthema morifolium (Ramat.), cultivated in Chuzhou, Anhui Province, China. Our previous studies have demonstrated that the total flavonoids extracted from Chuju (TFCJ) exhibit pharmacological efficacy against MIRI. This study will further elucidate its protective mechanism. Methods: We employed an integrative approach combining untargeted metabolomics, network pharmacology, molecular docking, and in vitro experiments to elucidate the mechanistic basis of TFCJ’s protective effects against MIRI. Results: TFCJ protected H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis. Integrated analyses identified Nrf2 as a central regulatory node activated by AKT signaling, which, in turn, modulates antioxidant protein expression and glutathione metabolism. Further in vitro experiments demonstrated that TFCJ induced AKT phosphorylation, thereby promoting Nrf2 activation and upregulating HO-1 expression, along with genes involved in glutathione synthesis. Conclusions: TFCJ exerts cardioprotective effects by activating the AKT-Nrf2 signaling pathway, regulating the expression of antioxidant and anti-apoptotic genes, and coordinating downstream glutathione metabolism, ultimately maintaining the oxidative-apoptotic balance in myocardial cells.

19 July 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
CWCong Wang
Cong Wang
YLYanran Li
Yanran Li
HMHuihui Meng
Huihui Meng
GSGaocheng Shi
Gaocheng Shi
YSYifan Sun
Yifan Sun
HYHao Yu
Hao Yu
Background: Osteoarthritis (OA) pathogenesis involves inflammatory-metabolic crosstalk driving cartilage destruction, yet the mechanisms of potential therapeutics like curcumin remain poorly defined. Methods: We integrated untargeted metabolomics, transcriptomic analysis of four GEO datasets (GSE12021, GSE55235, GSE55457, GSE82107), and three machine learning algorithms (LASSO, Random Forest, XGBoost) to characterize curcumin’s effects on IL-1β-induced human chondrocytes. Results: Metabolomic profiling demonstrated that IL-1β caused significant depletion of TCA cycle intermediates compared to blank controls, including pyruvate (log2FC = −1.34, p < 0.001) and malate (log2FC = −0.54, p < 0.001). High-dose curcumin (10 μM) significantly restored these metabolites towards normal levels (pyruvate log2FC = −0.01 vs. model; malate log2FC = −0.20 vs. model). Three machine learning algorithms converged on a six-gene inflammatory-metabolic signature (NFKBIA, MMP9, LCK, TDO2, HADHA, VEGFA), all showing excellent discriminative performance for OA (individual AUCs > 0.75). qRT-PCR validation confirmed that high-dose curcumin significantly downregulated pro-inflammatory genes compared to IL-1β treatment alone: JUN (log2FC = −0.68, p < 0.001), IL6 (log2FC = −1.13, p < 0.001), PTGS2 (log2FC = −0.94, p < 0.001), CCL20 (log2FC = −1.51, p < 0.001), and MMP9 (log2FC = −0.42, p < 0.001). Conversely, curcumin significantly upregulated the NF-κB inhibitor NFKBIA (log2FC = 0.40, p < 0.001), whose expression was initially suppressed by IL-1β (−log2FC = 0.76 vs. blank, p < 0.001). Conclusions: This systems-level analysis suggests curcumin modulates metabolic-inflammatory networks in OA chondrocytes, with NFKBIA as a candidate mediator, offering a mechanistic framework for drug-like molecule development despite curcumin’s own translational limitations.